SignatureFD’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

SignatureFD’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,497	Closed	-$289K	–	3338
2023 Q3	$289K	Sell	2,497 -7	-0.3%	-$752	0.01%	611
2023 Q2	$258K	Sell	2,504 -25	-1%	-$2.64K	0.01%	658
2023 Q1	$276K	Sell	2,529 -64	-2%	-$7.07K	0.01%	617
2022 Q4	$295K	Buy	2,593 +224	+9%	+$18.6K	0.01%	566
2022 Q3	$147K	Buy	2,369 +440	+23%	+$30.7K	0.01%	787
2022 Q2	$154K	Sell	1,929 -2,089	-52%	-$198K	0.01%	795
2022 Q1	$423K	Buy	4,018 +2,685	+201%	+$262K	0.01%	459
2021 Q4	$144K	Buy	1,333 +33	+3%	+$3.6K	﹤0.01%	861
2021 Q3	$142K	Buy	1,300 +153	+13%	+$15.9K	﹤0.01%	830
2021 Q2	$107K	Buy	1,147 +96	+9%	+$8.83K	﹤0.01%	928
2021 Q1	$97K	Buy	1,051 +154	+17%	+$13K	﹤0.01%	894
2020 Q4	$66K	Buy	897 +1	+0.1%	+$74	﹤0.01%	960
2020 Q3	$70K	Buy	896 +344	+62%	+$23.7K	﹤0.01%	844
2020 Q2	$31K	Buy	552 +133	+32%	+$5.69K	﹤0.01%	1150
2020 Q1	$12K	Buy	419 +373	+811%	+$12.6K	﹤0.01%	1425
2019 Q4	$2K	Hold	46	–	–	﹤0.01%	1972
2019 Q3	$1K	Hold	46	–	–	﹤0.01%	2077
2019 Q2	$1K	Hold	46	–	–	﹤0.01%	2010
2019 Q1	$1K	Hold	46	–	–	﹤0.01%	1947
2018 Q4	$1K	Hold	46	–	–	﹤0.01%	1913
2018 Q3	$1K	Sell	46 -650	-93%	-$12.4K	﹤0.01%	1887
2018 Q2	$12K	Buy	696 +650	+1,413%	+$9.91K	﹤0.01%	1354
2018 Q1	$1K	Buy	+46	New	+$680	﹤0.01%	1720

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SignatureFD's HZNP Position: Q4 2023 in Review

SignatureFD sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,497 shares — an estimated $289K sold.

SignatureFD first reported a position in HZNP in Q1 2018 and held it in 23 quarters. The position peaked at $423K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

SignatureFD reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
SignatureFD sold 2,497 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $289K.
SignatureFD first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 23 quarters.
SignatureFD's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $423K in Q1 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on SignatureFD's 13F filing for Q4 2023, filed 1 Feb 2024.